stock quote

ENDP (Common Stock)

Exchange

NASDAQ (US Dollar)

Price

$8.04

Change (%)

0.22 (2.88%)

Volume

2,879,505

Minimum 20 minute delay




press release

For a complete list of press releases, Click Here


state disclosures

California Transparency In Supply Chains Act Disclosure. Click Here.


featured product


See Full Prescribing Information



Par - People Achieving Results

Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life. Par, among the top four leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a research and development (R&D) pipeline of more than 200 potential new products. Par is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization. Learn more at www.endo.com

quality you can depend on

High-quality and cost-effective products with the highest level of customer service.

facilities & manufacturing

Learn more about our state of the art facilities, distribution center, and our manufacturing & packaging capabilities.

our generics products

We offer an extensive range of prescription and over-the-counter products across a wide range of therapeutic areas.